Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | LTA4H | P09960 | 2/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.35 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.35 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.35 |
| ▸ | BHMT | Q93088 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
| ▸ | ECE1 | P42892 | 1/20 | 0.34 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10453448 | 1.00 | DPP4 (0.41) | DPP4DPP8DPP9PTPN1LTA4H | |
| SCHEMBL10454018 | 1.00 | DPP4 (0.41) | DPP4DPP8DPP9PTPN1LTA4H | |
| SCHEMBL10453944 | 1.00 | DPP4 (0.41) | DPP4DPP8DPP9PTPN1LTA4H | |
| SCHEMBL1083057 | 1.00 | DPP4 (0.41) | DPP4DPP8DPP9PTPN1LTA4H | |
| Water SCHEMBL11698272 | 0.98 | DPP4 (0.40) | DPP4DPP8DPP9PTPN1LTA4H | |
| SCHEMBL11060719 | 0.92 | PTPN1 (0.45) | DPP4DPP8DPP9PTPN1ACE | |
| SCHEMBL30799694 | 0.86 | DPP4 (0.42) | DPP4DPP8DPP9ERAP2ERAP1 | |
| SCHEMBL31447508 | 0.86 | DPP4 (0.42) | DPP4DPP8DPP9ERAP2ERAP1 | |
| SCHEMBL2807590 | 0.86 | LTA4H (0.49) | DPP4DPP8DPP9LTA4HACE | |
| SCHEMBL10494263 | 0.86 | LTA4H (0.49) | DPP4DPP8DPP9LTA4HACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250386846-A1 | Food Compositions Including Aragonite | NANT HOLDINGS IP LLC (US) | 2025-12-25 | — | — | US | claimed |
| US-12089621-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2024-09-17 | — | — | US | claimed |
| US-20230354865-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-11-09 | — | — | US | claimed |
| US-11793224-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2023-10-24 | — | — | US | claimed |
| US-20230085907-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-03-23 | — | — | US | claimed |
| US-20210330724-A1 | CANNABIDIOL ALKALINE COMPOSITION | CHIROSYN DISCOVERY TECHNOLOGIES INC. (CA) | 2021-10-28 | — | — | US | claimed |
| WO-2020041860-A1 | CANNABIDIOL ALKALINE COMPOSITION | CHIROSYN DISCOVERY TECHNOLOGIES INC. (CA) | 2020-03-05 | — | — | WO | claimed |
| US-20090186127-A1 | Energy drink compositions | HERBALIFE INTERNATIONAL, INC. | 2009-07-23 | — | — | US | claimed |
| EP-1671550-A1 | Energy drink compositions | Herbalife International, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| US-6265008-B1 | MIXTURE CONTAINING PRESERVATIVE AND SODIUM POLYPHOSPHATE | THE PROCTER & GAMBLE CO. | 2001-07-24 | — | — | US | claimed |
| US-6126980-A | PRESERVATIVES OF SORBIC ACID, BENZOIC ACID AND ALKALI METAL SALTS | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-03 | — | — | US | claimed |
| US-20240058293-A1 | Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto | UNIV EMORY (US) | 2024-02-22 | — | — | US | disclosed |
| US-20230404113-A1 | FLAVORING COMPOSITION CONCENTRATES | SOLUBLE TECHNOLOGIES GROUP, LLC | 2023-12-21 | — | — | US | disclosed |
| US-11826336-B2 | Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto | EMORY UNIVERSITY (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230354865-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-11-09 | — | — | US | disclosed |
| US-4375430-A | Processes for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1983-03-01 | — | — | US | disclosed |
| US-4375430-A | Processes for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1983-03-01 | — | — | US | disclosed |
| EP-0069811-A1 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| EP-0034876-A2 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1981-09-02 | — | — | EP | disclosed |
| US-4012367-A | Anti-ulcer polypeptides containing L-aspartic acid and intermediates thereto | G. D. SEARLE & CO. (US) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210330724-A1 | CANNABIDIOL ALKALINE COMPOSITION | ALPL, CNR2, PHOSPHO1 | DPP4 3012/4885DPP8 1824/4885DPP9 1569/4885 |
| US-20250386846-A1 | Food Compositions Including Aragonite | PLCG2, PLCG1, PLCB3 | DPP4 2516/4885DPP8 3465/4885DPP9 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.